Tallie Z. Baram, MD, talks about how adding a measure of childhood unpredictability to ACEs screening may help pediatricians identify children at risk for mental health problems.
|Videos|December 27, 2021
How a pediatrician uses chalk art to express herself
Author(s)Miranda Hester
A pediatrician shares how the hobby she started during the pandemic has helped her.
Advertisement
Alisa Helfgott, DO, a pediatrician at Northwell Health in Howard Beach, New York and also Assistant Professor of Pediatrics at Zucker School of Medicine at Hofstra/Northwell, discusses the chalk art hobby that she started in earnest during the pandemic and how she chooses what she draws.
Advertisement
Related to this article
Bradley Peterson, MD, discusses when pediatricians should consider adding a second treatment for pediatric anxiety and why improvement may continue well beyond the first 3 months of therapy.
Bradley Peterson, MD, discusses how treatment preferences, access, tolerability, and patient characteristics can guide pediatric anxiety care when CBT and medication provide similar overall benefits.
CBT and fluoxetine both reduced pediatric anxiety, while starting with CBT before adding medication showed advantages on several outcomes.
Pediatric psychiatric diagnoses and treatment rose above prepandemic levels, with notable increases in medication initiation and care among girls.
Pediatric mental health treatment exceeded prepandemic levels, with antidepressant initiation rising sharply among girls after COVID-19.
John Walkup, MD, says collaborative care, education, and psychiatric consultation can help pediatricians manage children's mental health needs.
John Walkup, MD, says pediatricians can address growing mental health needs by identifying risk factors and providing guidance early in childhood.
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Updated AAP guidance changes iron deficiency screening and treatment in children
2
Tezepelumab meets co-primary and secondary endpoints in phase 3 eosinophilic esophagitis trial
3
FDA approves levacetylleucine as first treatment for ataxia in ataxia-telangiectasia
4
Childhood unpredictability may identify mental health risk missed by ACEs screening
5